These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32982178)

  • 1. Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.
    Tan YQ; Chen HW; Li J
    Drug Des Devel Ther; 2020; 14():3731-3746. PubMed ID: 32982178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV.
    Xu Z; Zhou H; Zhang Y; Cheng Z; Wan M; Qin W; Li P; Feng J; Shao S; Xue W; Guo H; Liu B
    Biomed Pharmacother; 2023 Dec; 168():115752. PubMed ID: 37875045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated role of astragaloside IV in heart failure.
    Zang Y; Wan J; Zhang Z; Huang S; Liu X; Zhang W
    Biomed Pharmacother; 2020 Jun; 126():110012. PubMed ID: 32213428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis.
    Ren C; Zhao X; Liu K; Wang L; Chen Q; Jiang H; Gao X; Lv X; Zhi X; Wu X; Li Y
    J Ethnopharmacol; 2023 Apr; 305():116128. PubMed ID: 36623754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress of astragaloside IV in the treatment of atopic diseases.
    Yu S; Peng W; Qiu F; Zhang G
    Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
    Zhang J; Wu C; Gao L; Du G; Qin X
    Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological effects of Astragaloside IV: a literature review.
    Ren S; Zhang H; Mu Y; Sun M; Liu P
    J Tradit Chin Med; 2013 Jun; 33(3):413-6. PubMed ID: 24024343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.
    Luo Y; Qin Z; Hong Z; Zhang X; Ding D; Fu JH; Zhang WD; Chen J
    Neurosci Lett; 2004 Jun; 363(3):218-23. PubMed ID: 15182947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress of astragaloside IV in treating acute kidney injury.
    Liu Y; Huang Y; Sun D; Ye N; Chen T; Yang M; Zhou L; Zou H
    Int Urol Nephrol; 2024 Aug; 56(8):2645-2650. PubMed ID: 38494585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling the metabolism of astragaloside IV by ultra performance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry.
    Cheng XD; Wei MG
    Molecules; 2014 Nov; 19(11):18881-96. PubMed ID: 25407723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research review on the pharmacological effects of astragaloside IV.
    Li L; Hou X; Xu R; Liu C; Tu M
    Fundam Clin Pharmacol; 2017 Feb; 31(1):17-36. PubMed ID: 27567103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecological niche modeling of Astragalus membranaceus var. mongholicus medicinal plants in Inner Mongolia, China.
    Yang M; Li Z; Liu L; Bo A; Zhang C; Li M
    Sci Rep; 2020 Jul; 10(1):12482. PubMed ID: 32719330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction Optimization of Astragaloside IV by Response Surface Methodology and Evaluation of Its Stability during Sterilization and Storage.
    Xu L; Wei K; Jiang J; Zhang L
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33924283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
    Qiu LH; Xie XJ; Zhang BQ
    Biol Pharm Bull; 2010; 33(4):641-6. PubMed ID: 20410599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review.
    Zhang K; Pugliese M; Pugliese A; Passantino A
    Mini Rev Med Chem; 2015; 15(4):315-29. PubMed ID: 25723453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV: A promising natural neuroprotective agent for neurological disorders.
    Yao M; Zhang L; Wang L
    Biomed Pharmacother; 2023 Mar; 159():114229. PubMed ID: 36652731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway.
    Wei Y; Wu Y; Feng K; Zhao Y; Tao R; Xu H; Tang Y
    J Ethnopharmacol; 2020 Mar; 249():112404. PubMed ID: 31739105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
    Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
    J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
    You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo.
    Xu XL; Ji H; Gu SY; Shao Q; Huang QJ; Cheng YP
    Eur J Pharmacol; 2007 Jul; 568(1-3):203-12. PubMed ID: 17509559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.